Top Markets
Coin of the day
Allergy Therapeutics plc Allergy Therapeutics plc

Allergy Therapeutics plc

AGY
Classificação em ações #35053
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and... Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. Furthermore, Allergy Therapeutics is actively advancing new vaccine candidates designed to address sensitivities to trees, grass, house dust mites, animal dander, and peanuts. With operations spanning Central Europe, Southern Europe, the United Kingdom, and various other international markets, Allergy Therapeutics plc was established in 2004 and is headquartered in Worthing, UK.
Preço da ação
$0.07143683
Última sincronização: 2026-08-14
Valor de mercado
$4.52M
Variação (1 dia)
0.00%
Variação (1 ano)
-37.27%
País
GB
Negociar Allergy Therapeutics plc (AGY)

Categoria

Histórico de desdobramentos de ações de Allergy Therapeutics plc (AGY)
As ações Allergy Therapeutics plc (símbolo: AGY) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 16, 2026.
Uma ação AGY comprada antes de Aug 16, 2026 equivaleria hoje a 0 ações AGY.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes